top of page
Biologics CMC Series, Part 6: Biologics Process Validation — Are Three Batches Enough for Commercial Manufacturing?
Are three batches enough? Explore the process validation lifecycle, PPQ evidence, and continued monitoring through a hypothetical monoclonal antibody program.

Jason Lu
Sep 207 min read
bottom of page
